[Treatment of metabolic acidosis in patients with chronic renal insufficiency].
D000085:Acetates / Q000627:therapeutic use; D000141:Acidosis, Renal Tubular / Q000188:drug therapy* / Q000209:etiology; D000328:Adult; D001639:Bicarbonates / Q000097:blood / Q000627:therapeutic use; D002118:Calcium / Q000097:blood / Q000627:therapeutic use; D002951:Citrates / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D004039:Diet, Sodium-Restricted; D005260:Female; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D011188:Potassium / Q000627:therapeutic use; D011704:Pyelonephritis / Q000150:complications; D012964:Sodium / Q000627:therapeutic use; D013997:Time Factors
D000085:Acetates; D001639:Bicarbonates; D002951:Citrates; D012964:Sodium; D003404:Creatinine; D011188:Potassium; D002118:Calcium
Zur Behandlung der metabolischen Azidose bei Patienten mit chronischer Niereninsuffizienz.